Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review

Cannabis sativa is recognized for its chemical diversity and therapeutic potential, particularly in addressing neurodegenerative diseases such as Alzheimer's disease (AD). Given the complexity of AD, where single-target therapies often prove inadequate, a multi-target approach utilizing cannabi...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanane Doumar, Hicham El Mostafi, Aboubaker Elhessni, Mohamed Ebn Touhami, Abdelhalem Mesfioui
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:IBRO Neuroscience Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667242124001192
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553736628961280
author Hanane Doumar
Hicham El Mostafi
Aboubaker Elhessni
Mohamed Ebn Touhami
Abdelhalem Mesfioui
author_facet Hanane Doumar
Hicham El Mostafi
Aboubaker Elhessni
Mohamed Ebn Touhami
Abdelhalem Mesfioui
author_sort Hanane Doumar
collection DOAJ
description Cannabis sativa is recognized for its chemical diversity and therapeutic potential, particularly in addressing neurodegenerative diseases such as Alzheimer's disease (AD). Given the complexity of AD, where single-target therapies often prove inadequate, a multi-target approach utilizing cannabis-derived compounds may offer promising alternatives. This review first highlights the chemical diversity of cannabis by categorizing its compounds into cannabinoids and non-cannabinoids. It then examines studies investigating the effects of these compounds on AD-related pathological features. By synthesizing existing knowledge, identifying research gaps, and facilitating comparative analysis, this review aims to advance future research and understanding. It underscores cannabis's potential as a multi-target therapeutic strategy for AD, contributing valuable insights to ongoing scientific discussions.
format Article
id doaj-art-47984fb509dc447282a223a910a026be
institution Kabale University
issn 2667-2421
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series IBRO Neuroscience Reports
spelling doaj-art-47984fb509dc447282a223a910a026be2025-01-09T06:14:54ZengElsevierIBRO Neuroscience Reports2667-24212025-06-011896119Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A reviewHanane Doumar0Hicham El Mostafi1Aboubaker Elhessni2Mohamed Ebn Touhami3Abdelhalem Mesfioui4Laboratory of Biology and Health, Department of Biology, Faculty of Sciences, Ibn Tofail University, Kenitra, MoroccoLaboratory of Biology and Health, Department of Biology, Faculty of Sciences, Ibn Tofail University, Kenitra, Morocco; Correspondence to: Biology and Health Laboratory, Department of Biology, Faculty of Sciences, Ibn Tofail University, B.P 133, Kenitra 14000, Morocco.Laboratory of Biology and Health, Department of Biology, Faculty of Sciences, Ibn Tofail University, Kenitra, MoroccoLaboratory of Materials Engineering and Environment: Modeling and Application, Department of Chemistry, Faculty of Sciences, Ibn Tofail University, Kenitra, MoroccoLaboratory of Biology and Health, Department of Biology, Faculty of Sciences, Ibn Tofail University, Kenitra, MoroccoCannabis sativa is recognized for its chemical diversity and therapeutic potential, particularly in addressing neurodegenerative diseases such as Alzheimer's disease (AD). Given the complexity of AD, where single-target therapies often prove inadequate, a multi-target approach utilizing cannabis-derived compounds may offer promising alternatives. This review first highlights the chemical diversity of cannabis by categorizing its compounds into cannabinoids and non-cannabinoids. It then examines studies investigating the effects of these compounds on AD-related pathological features. By synthesizing existing knowledge, identifying research gaps, and facilitating comparative analysis, this review aims to advance future research and understanding. It underscores cannabis's potential as a multi-target therapeutic strategy for AD, contributing valuable insights to ongoing scientific discussions.http://www.sciencedirect.com/science/article/pii/S2667242124001192Cannabis sativaAlzheimer's diseaseNeuroprotectionCannabinoidsMulti-target therapy
spellingShingle Hanane Doumar
Hicham El Mostafi
Aboubaker Elhessni
Mohamed Ebn Touhami
Abdelhalem Mesfioui
Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review
IBRO Neuroscience Reports
Cannabis sativa
Alzheimer's disease
Neuroprotection
Cannabinoids
Multi-target therapy
title Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review
title_full Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review
title_fullStr Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review
title_full_unstemmed Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review
title_short Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review
title_sort exploring the diversity of cannabis cannabinoid and non cannabinoid compounds and their roles in alzheimer s disease a review
topic Cannabis sativa
Alzheimer's disease
Neuroprotection
Cannabinoids
Multi-target therapy
url http://www.sciencedirect.com/science/article/pii/S2667242124001192
work_keys_str_mv AT hananedoumar exploringthediversityofcannabiscannabinoidandnoncannabinoidcompoundsandtheirrolesinalzheimersdiseaseareview
AT hichamelmostafi exploringthediversityofcannabiscannabinoidandnoncannabinoidcompoundsandtheirrolesinalzheimersdiseaseareview
AT aboubakerelhessni exploringthediversityofcannabiscannabinoidandnoncannabinoidcompoundsandtheirrolesinalzheimersdiseaseareview
AT mohamedebntouhami exploringthediversityofcannabiscannabinoidandnoncannabinoidcompoundsandtheirrolesinalzheimersdiseaseareview
AT abdelhalemmesfioui exploringthediversityofcannabiscannabinoidandnoncannabinoidcompoundsandtheirrolesinalzheimersdiseaseareview